ArticleJTO clinical and research reports2025

Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated

Makoto Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.